| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/10/1993 | WO1993011246A1 Novel proteases with dna fragmenting activity |
| 06/10/1993 | WO1993011238A1 Humanized b-b10, an anti-il2 receptor antibody |
| 06/10/1993 | WO1993011145A1 Indolopyrrolocarbazole derivatives |
| 06/10/1993 | WO1993011130A1 Rapamycin derivative and its medicinal use |
| 06/10/1993 | WO1993011105A1 Leukotriene-b4 derivatives, process for preparing the same and medicaments |
| 06/10/1993 | WO1993011104A1 Organic salts of n, n'-diacetyl cystine |
| 06/10/1993 | WO1993011099A1 Nitroaniline derivatives and their use as antitumor agents |
| 06/10/1993 | WO1993010814A1 Anti-cancer immunotherapeutic vector constructs |
| 06/10/1993 | WO1993010808A1 INHIBITING TRANSFORMING GROWTH FACTOR β TO PREVENT ACCUMULATION OF EXTRACELLULAR MATRIX |
| 06/10/1993 | WO1993010805A1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
| 06/10/1993 | WO1993010792A1 Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours |
| 06/10/1993 | WO1993010791A1 Use of a known chemical compound for the production of a pharmaceutical composition for topical application |
| 06/10/1993 | WO1993010763A1 Antitumor vaccines |
| 06/10/1993 | WO1993010743A2 Controlled use of polyether-substituted tumor agents in diagnosis and therapy |
| 06/10/1993 | WO1993010741A2 Sex steroid activity inhibitors |
| 06/10/1993 | CA2124852A1 Use of a known chemical compound for the production of a pharmaceutical composition for topical application |
| 06/10/1993 | CA2124591A1 Inhibiting transforming growth factor .beta. to prevent accumulation of extracellular matrix |
| 06/10/1993 | CA2124358A1 Novel proteases with dna fragmenting activity |
| 06/10/1993 | CA2123516A1 Organic salts of n,n'-diacetyl cystine |
| 06/10/1993 | CA2122992A1 Leukotriene-b derivatives, process for preparing the same and medicaments |
| 06/09/1993 | EP0545441A1 Substituted benzoylurea derivatives or their salts, processes for their production and antitumor compositions containing them |
| 06/09/1993 | EP0545195A1 Indolopyrrolocarbazole derivatives |
| 06/09/1993 | EP0545016A1 Composition for nucleic acid complex transfer in suspension eukaryotic cells |
| 06/09/1993 | EP0544878A1 Asialoglycoprotein-conjugated medicinal agent |
| 06/09/1993 | EP0544860A1 Novel biologically active peptide compositions and uses therefor |
| 06/09/1993 | EP0544815A1 Peptides from the GMP-140 lectinbindingdomain and selectin binding ligands on carbonhydrates |
| 06/09/1993 | EP0478708A4 Formation of triple helix complexes of double stranded dna using nucleoside oligomers |
| 06/09/1993 | EP0358657B1 Poly(deoxyribonucleotides), pharmaceutical compositions, use and preparation of the poly(deoxyribonucleotides) |
| 06/08/1993 | US5218115 Cholecystokinin antagonists |
| 06/08/1993 | US5217955 Treating colon, prostate or breast cancer in mammals |
| 06/06/1993 | CA2084428A1 Substituted benzoylurea derivatives or their salts, processes for their production and antitumor compositions containing them |
| 06/06/1993 | CA2082982A1 Compounds useful as antiproliferative agents |
| 06/02/1993 | EP0543922A1 Methods for inducing cell differentiation using ceramides |
| 06/02/1993 | EP0543871A1 Stable doxorubicin/liposome composition |
| 06/02/1993 | EP0369000A4 Macrocyclic complexes of yttrium, the lanthanides and the actinides having peripheral coupling functionalities |
| 06/02/1993 | CN1072687A Anti-alphab-integrin antibodies |
| 06/02/1993 | CN1072686A Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and their use. |
| 06/02/1993 | CN1072683A 水溶性喜树碱衍生物 Water-soluble derivative of camptothecin |
| 06/01/1993 | US5216148 Treating, preventing neoplasms, dermatoses, aging of skin |
| 06/01/1993 | US5216128 IFN-β2/IL-6 receptor its preparation and pharmaceutical compositions containing it |
| 06/01/1993 | US5216026 Antitumor compositions and methods of treatment |
| 06/01/1993 | US5216024 Cell growth inhibitors and methods of treating cancer and cell proliferative diseases |
| 06/01/1993 | US5216011 Solvent mixture consisting of propylene glycol and water |
| 06/01/1993 | US5215913 IgG-1 human monoclonal antibody reactive with an HIV-1 antigen and methods of use |
| 06/01/1993 | CA1318670C 2-acyloxypropylamine derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| 06/01/1993 | CA1318665C2 4-demethoxy-4-amino-anthracyclines |
| 06/01/1993 | CA1318615C Radiohalogenated compounds for site specific labeling |
| 06/01/1993 | CA1318586C Treatment of tumors with autologous lak cells, interleukin-2 and an ornithine decarboxylase inhibitor |
| 05/27/1993 | WO1993010219A1 Cellular composition for the treatment of human or animal organisms |
| 05/27/1993 | WO1993010137A1 2'-deoxy-2'-fluorocoformycin and stereoisomers thereof |
| 05/27/1993 | WO1993010134A1 Ganglioside analogs |
| 05/27/1993 | WO1993010116A1 Triazine derivatives for enhancing antitumor activity |
| 05/27/1993 | WO1993010113A1 Novel benzothiophene derivative |
| 05/27/1993 | WO1993009816A1 Method for diagnosing and treating cancer |
| 05/27/1993 | WO1993009813A1 Therapeutic compounds |
| 05/27/1993 | WO1993009812A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 05/27/1993 | WO1993009795A1 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them |
| 05/27/1993 | WO1993009785A1 Risedronate delayed-release compositions |
| 05/27/1993 | WO1993009782A1 Combination chemotherapy |
| 05/27/1993 | WO1993009777A1 Tocotrienols and tocotrienol-like compounds and methods for their use |
| 05/27/1993 | WO1993009776A1 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones |
| 05/27/1993 | CA2378820A1 Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
| 05/27/1993 | CA2124086A1 Tocotrienols and tocotrienol-like compounds and methods for their use |
| 05/27/1993 | CA2123588A1 Method for diagnosing and treating cancer |
| 05/27/1993 | CA2123402A1 Triazine derivatives for enhancing antitumor activity |
| 05/27/1993 | CA2123213A1 Ganglioside analogs |
| 05/27/1993 | CA2117282A1 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprosing them |
| 05/26/1993 | EP0543659A1 Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma |
| 05/26/1993 | EP0543653A1 Dipyridamole for the treatment of proliferative diseases |
| 05/26/1993 | EP0543516A1 Hapalindole alkaloids as antifungal and antitumor agents |
| 05/26/1993 | EP0543417A1 Tocotrienols and tocotrienol-like compounds and methods for their use |
| 05/26/1993 | EP0542971A1 CLONING AND RECOMBINANT PRODUCTION OF RECEPTOR(S) OF THE ACTIVIN/TGF-$g(b) SUPERFAMILY |
| 05/26/1993 | EP0542934A1 Method of treating benign and malignant proliferative skin disease |
| 05/26/1993 | EP0542887A1 Psoralen conjugated methylphosphonate oligonucleotides as therapeutic agents for chronic myelogenous leukemia |
| 05/26/1993 | EP0542807A1 Use of 2-phenyl-1,2-benzisoselenazol-3(2h)-one |
| 05/26/1993 | EP0542756A1 Method of introducing a peptide into the cytosol |
| 05/26/1993 | EP0527802A4 Ligand for the neu gene product |
| 05/26/1993 | EP0401256B1 Optically pure dexniguldipine and its derivatives for treating tumorous diseases |
| 05/26/1993 | EP0389543B1 Ultrasonic or shock wave operating process and agent for implementing said process |
| 05/26/1993 | CN1020924C Production of pluripotent granule cell colony stimulating factor |
| 05/26/1993 | CN1020903C (1h-imidazol-1-ylmethyl) substituted benzimidazole derivatives and the preparation therefor |
| 05/25/1993 | US5213804 Localized delivery of antibiotic to tumor via bloodstream, encapsulation in liposome |
| 05/25/1993 | CA1318457C Partially retro-inverted tuftsin analogues, method for the preparation thereof and pharmaceutical compositions containing them |
| 05/25/1993 | CA1318456C Peptides |
| 05/25/1993 | CA1318325C 1-substituted tetralin derivatives, their preparation and their use |
| 05/25/1993 | CA1318251C Combined use of an antigestagen and a progesterone systhesis inhibitor of the trilostane and epostane type |
| 05/22/1993 | CA2083359A1 Melatonin derivatives and combinations with antiestrogen compounds for treating mamalian breast carcinoma |
| 05/22/1993 | CA2083223A1 Local delivery of dipyridamole for the treatment of proliferative diseases |
| 05/19/1993 | EP0541720A1 Golfomycin derivatives: novel fused ring cyclodecadiyne derivatives |
| 05/19/1993 | EP0541670A1 Phosphene oxide-terminated allene-ene-yne dna-cleaving, antitumor and antibiotic molecules |
| 05/19/1993 | EP0541654A1 Bombesin antagonists |
| 05/18/1993 | US5212290 Monoclonal and polyclonal antibodies |
| 05/18/1993 | US5212166 Antiandrogens or 5-alpha reductase inhibitors |
| 05/18/1993 | US5212161 Antitumor |
| 05/18/1993 | US5212085 Monoclonal antibodies |
| 05/18/1993 | US5211945 Compositions and methods for modulating the effect of tnf and il-1 |
| 05/18/1993 | US5211938 Method of detection of malignant and non-malignant lesions by photochemotherapy of protoporphyrin IX percursors |
| 05/18/1993 | US5211657 Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides |
| 05/18/1993 | CA1317973C Tetralin derivatives, their preparation and their use |
| 05/18/1993 | CA1317942C 5-hetero-or aryl-substituted-imidazol¬2,1-a| isoquinolines |